U.S. flag An official website of the United States government
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Hashimoto Shokuryo Kogyo Co., Ltd. - 08/03/2015
  1. Warning Letters


Hashimoto Shokuryo Kogyo Co., Ltd.

Hashimoto Shokuryo Kogyo Co., Ltd.

United States

Issuing Office:

United States


Department of Health and Human Services' logoDepartment of Health and Human Services

Public Health Service
 Food and Drug Administration
College Park, MD 20740

August 3, 2015

Mr. Hashimoto Toshikatsu, President
Hashimoto Shokuryo Kogyo Co. Ltd
2-17-29 Sawaragi-Nishi
Ibaraki City, Osaka
567-0868 Japan

Dear Mr. Hashimoto Toshikatsu:

The Food and Drug Administration (FDA) has completed an evaluation of your firm’s corrective actions in response to our Warning Letter 451034, issued March 4, 2015. Based on our evaluation, it appears you have addressed the violations contained in the Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.



Catherine Vieweg
Compliance Officer
Food Adulteration Assessment Branch
Division of Enforcement
Office of Compliance
Center for Food Safety and Applied Nutrition

Back to Top